AstraZeneca unveils second brand play in India

 
• By Anju Ghangurde

AstraZeneca appears to be the latest to join a clutch of foreign firms deploying the second-brand approach to penetrate the Indian market more effectively.

More from Alimentary/Metabolic

More from Therapy Areas